Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease

NCT05639192 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

34

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of patients

Conditions

COVID-19

Interventions

BIOLOGICAL: Asunercept
OTHER: Placebo

Sponsor

Apogenix GmbH